U.S. Real Estate Stock News

Event driven spotlight on Genuine Parts stock Genuine Parts (GPC) has moved back onto investor radars after its annual shareholder meeting, where the company outlined plans to separate its automotive and industrial businesses into two independent, publicly traded companies. This planned split, paired with a higher 2026 dividend and reaffirmed guidance, provides a fresh set of milestones to monitor when comparing Genuine Parts stock with your income and total return goals. See our latest...

In the first quarter of 2026, Chipotle Mexican Grill reported revenue of US$3,088.24 million, up from US$2,875.25 million a year earlier, while net income fell to US$302.82 million and the company continued expanding with plans for 350 to 370 new restaurant openings this year. Alongside fresh leadership appointments in brand and digital, Chipotle ramped up menu innovation with the return of its ChipotleHoney Chicken, enhanced its loyalty program, expanded technology pilots like...

In recent weeks, Arrow Electronics has attracted attention as earnings estimates edged higher and research firm Zacks assigned the stock a Rank #2 (Buy) with a Momentum Style Score of B, alongside new SEC filings showing Vanguard entities holding passive stakes above 5% of outstanding shares as of March 31, 2026. This combination of incremental earnings upgrades, favorable momentum indicators, and sizeable passive institutional ownership highlights shifting sentiment toward Arrow’s...

IDEAYA Biosciences recently announced that the FDA has agreed to review its New Drug Application for darovasertib combined with crizotinib in first-line HLA*A2-negative metastatic uveal melanoma under the Oncology Center of Excellence Real-Time Oncology Review program, following positive Phase 2/3 OptimUM-02 trial results that met the study’s primary endpoint. This regulatory milestone highlights darovasertib’s potential to address a genetically defined segment of a rare eye cancer with...

In late April 2026, Merit Medical Systems reported first-quarter 2026 results showing US$381.88 million in sales and US$41 million in net income, with both basic and diluted earnings per share from continuing operations rising versus a year earlier and adjusted earnings and margins coming in ahead of analyst expectations. At the same time, the company slightly raised its full-year 2026 revenue guidance to about US$1.62 billion and expanded its oncology platform through the Viewpoint Medical...

Avantor (AVTR) is in the spotlight after its CFO departure, recent CEO change and the ongoing Revival turnaround program, as the company reports flat year-on-year quarterly sales and keeps forward guidance intact. See our latest analysis for Avantor. Avantor's share price has weakened over time, with a 90 day share price return of 26.64% and a 1 year total shareholder return of 36.98%. This suggests sentiment has softened even as management pushes the Revival program and leadership...

Spyre Therapeutics (SYRE) recently closed an underwritten public offering that raised about US$463.5 million. This provides the company with additional capital to fund its inflammatory and rheumatic disease programs and has drawn fresh attention from Wall Street coverage. See our latest analysis for Spyre Therapeutics. The stock has been volatile around these announcements, with a 1-day share price return decline of 6.76% and a 7-day share price return decline of 3.45%. However, a 30-day...

Why Yum! Brands (YUM) is on investors’ radar today Yum! Brands (YUM) is drawing attention after recent trading left the stock with a one-month return of 1.45% and a past three-month move of 0.24%, alongside reported annual revenue of US$8.49b and net income of US$1.74b. See our latest analysis for Yum! Brands. At a share price of US$158.36, Yum! Brands has recently seen a 2.06% 7 day share price return and a 5.23% year to date share price return, while the 1 year total shareholder return...

Why the new Team USA program matters for PennyMac Mortgage Investment Trust (PMT) PennyMac Mortgage Investment Trust (PMT) is in focus after launching the Welcome Home: Athlete Mortgage Program with PennyMac Financial Services. The program targets Team USA athletes with tailored lending support, benefits, and education. See our latest analysis for PennyMac Mortgage Investment Trust. The Athlete Mortgage Program arrives as PMT’s share price trades at US$12.33, with a 30 day share price return...

Cousins Properties reported first-quarter 2026 results on April 29, 2026, with revenue rising to US$263.11 million while moving from net income of US$20.9 million a year earlier to a net loss of US$24.86 million, largely due to a US$36.6 million impairment on its One Eleven Congress asset. Despite the accounting loss, the company showed resilient operations with strong Sun Belt leasing activity, higher occupancy, an increase in funds from operations guidance, and an expanded US$500 million...

In late April 2026, Tenet Healthcare reported first-quarter 2026 results with net operating revenues of about US$5.37 billion and net income of US$702 million, comfortably ahead of the prior year, and issued full-year 2026 guidance calling for net operating revenues of US$21.50 billion to US$22.30 billion and net income of US$2.61 billion to US$2.84 billion. Management highlighted that expense controls, higher-acuity procedures in its ambulatory surgery centers, and AI-driven efficiency...

Bread Financial Holdings, Inc. recently reported first-quarter 2026 results showing higher net interest income of US$1,067 million and net income of US$181 million compared with a year earlier. At the same time, the board confirmed second-quarter 2026 common and preferred dividends and completed a share repurchase program totaling 4,573,205 shares for US$309.99 million, underscoring ongoing capital returns to shareholders. Next, we’ll explore how stronger earnings alongside this completed...

In recent days, several major banks updated their views on J. M. Smucker, with Morgan Stanley and Stifel reiterating cautious stances while BTIG began coverage with a more optimistic outlook focused on the company’s coffee business and changing consumer landscape. At the same time, Vanguard disclosed a sizeable passive ownership stake of more than 7 million shares, underlining continued institutional interest in the stock despite differing analyst opinions on its prospects. We’ll now look at...

Assessing recent performance and fundamentals Broadstone Net Lease (BNL) has been drawing attention after a period of mixed short term returns, with a 1 day decline of 0.8% and 7 day decline of 1.6%, alongside positive recent performance. The stock shows gains of 5.5% over the past month and 4.9% over the past 3 months. This has contributed to a 12.5% year to date return and a 31% total return over the past year for investors tracking its progress. See our latest analysis for Broadstone Net...

What recent performance suggests about Nelnet’s stock Nelnet (NNI) has drawn fresh attention after a recent move in its share price, with the stock roughly flat over the past week but showing a gain over the past month and past 3 months. See our latest analysis for Nelnet. Looking beyond the latest move, Nelnet’s 30 day share price return of 9.43% and year to date share price return of 9.82% sit alongside a 1 year total shareholder return of 33.95%. Taken together, these figures suggest that...

Performance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months. For income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment. See our latest analysis for Sabra Health Care REIT. At a share...

If you are wondering whether Wyndham Hotels & Resorts stock still offers value after recent swings, you are not alone. The share price closed at US$80.84, with a 5.3% decline over the last 7 days and a 1.6% decline over 30 days, while the stock shows a 7.4% return year to date, a 1.9% decline over 1 year, 26.8% over 3 years, and 20.8% over 5 years. Recent headlines around Wyndham have focused on its position in the hotel and resort industry and how investors are weighing the balance between...

CACI International Inc. recently reported third-quarter fiscal 2026 results, with sales of US$2,351 million and net income of US$130.39 million, and updated full-year guidance to revenue of US$9,500 million–US$9,600 million and net income of US$481 million–US$496 million. The company’s higher year-on-year sales and earnings, alongside raised full-year guidance, underline management’s confidence in its operating performance and earnings profile. We’ll now examine how CACI’s raised full-year...

In the first quarter of 2026, Waste Connections reported higher sales of US$2,370.63 million but lower net income of US$219.34 million year over year, while maintaining its regular US$0.35 quarterly dividend and continuing share repurchases under its existing buyback program. Management also signaled an “above-average” year for acquisitions, citing a robust pipeline including about US$100 million in annualized revenue from deals expected to close by early third quarter, alongside early gains...

Quantum computing is moving from theory to tangible products at the same time as investors are dealing with higher inflation, elevated bond yields and energy related uncertainty. In this setting, some prefer themes where long term research and intellectual property matter as much as near term growth. The Quantum Computing Stocks screener focuses on companies working on hardware, software and research around quantum algorithms and superconducting qubits. It can help you quickly narrow a...

Neogen (NEOG) came into focus after a recent move in its share price, with the stock last closing at $9.53. For investors, that price helps frame the discussion around value and expectations. See our latest analysis for Neogen. That recent move sits within a mixed picture, with a strong year to date share price return of 36.14% and a 1 year total shareholder return of 68.97% contrasting with a 3 year total shareholder return of 44.46% and a 5 year total shareholder return of 79.38%. This...

Cardinal Health (CAH) just delivered quarterly earnings that topped profit expectations, prompting management to lift full year adjusted EPS guidance, even as revenue shortfalls, pricing pressure and impairment charges kept investor attention on execution. See our latest analysis for Cardinal Health. At a share price of US$195.24, Cardinal Health has retreated with a 30 day share price return of 8.79% and a 90 day share price return of 10.44%, even as repeated earnings beats, raised guidance...

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...

In April 2026, Target Hospitality Corp. completed a follow-on equity offering of 7,000,000 common shares, raising approximately US$98,000,000 at US$14 per share with a US$0.735 discount per share. This fresh equity capital, raised through a sizeable common stock issuance, has implications for existing shareholders, future funding flexibility, and the company’s long-term capital structure. Next, we’ll examine how this US$98,000,000 equity raise may reshape Target Hospitality’s investment...